Clinical trial
Pamidronate to Treat Osteogenesis Imperfecta in Children
NCT00005901 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00005901 |
|---|---|
| Title | Pamidronate to Treat Osteogenesis Imperfecta in Children |
| Official title | A Trial of Pamidronate in Children With Osteogenesis Imperfecta |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Collaborators | National Institutes of Health Clinical Center (CC) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteogenesis Imperfecta |
| Intervention type | Drug |
| Interventions | Pamidronate (Aredia) |
| Enrollment | 34 |
| Start date | Jun 1, 2000 |
| Primary completion | May 1, 2014 |
| Completion | Mar 1, 2015 |
| First posted | Jun 7, 2000 |
| Last update posted | Mar 1, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: